# Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome

> **NCT01601028** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 39 (actual)

## Conditions studied

- Autoimmune Diseases
- Sjogren's Syndrome
- Dry Eye

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01601028
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2013-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601028, "Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01601028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*